Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 17, 2017
Pharmacy Choice - News - Drug Delivery Systems - August 17, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/10/17 - Investigators from University of Basel Report New Data on Drug Delivery Systems (PEG-PCL-based nanomedicines: A biodegradable drug delivery system...
By a News Reporter-Staff News Editor at Gene Therapy Weekly Current study results on Drugs and Therapies- Drug Delivery Systems have been published. The news correspondents obtained a quote from the research from the University of Basel, "In this review, we discuss state-of-the-art nanomedicines based on PEG-PCL that have been investigated in a p
8/9/17 - "Novel Pulsatile Drug Delivery System" in Patent Application Approval Process (USPTO 20170202786)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Patel, Jayendrakumar Dasharathlal; Patel, Dasharathbhai Trikambhai; Patel, Shwetaben Dasharathbhai, filed on January 20, 2016, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondent
8/9/17 - ANTARES PHARMA, INC. (NASDAQ:ATRS) Files An 8-K Regulation FD Disclosure
ANTARES PHARMA, INC. (NASDAQ:ATRS) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure. A copy of Antares Pharma, Inc.'s (the Company) updated investor presentation slides that the Company intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Ite
8/9/17 - Aurobindo Receives FDA Approval for the line of OC tablets Aurovela
Release date- 08082017- East Windsor, N.J- Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Aurovela line of OC tablets. The Division of Bioequivalence has determined Aurobindo Pharma Limited's Aurovela to be bioequivalent and, therefore, therapeutically equivalent to Loestrin line of oral contrace
8/9/17 - Data on Drug Delivery Systems Discussed by Researchers at University of Palermo (Clay-based drug-delivery systems: what does the future hold?)
By a News Reporter-Staff News Editor at Biotech Week New research on Drugs and Therapies- Drug Delivery Systems is the subject of a report. According to news reporting originating in Palermo, Italy, by NewsRx journalists, research stated, "Clays for drug delivery have been used from ancient time due to the large availability of clay minerals and
8/9/17 - DURECT CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
This Management's Discussion and Analysis of Financial Condition and Results of Operations for the three and six months ended June 30, 2017 and 2016 should be read in conjunction with our annual report on Form 10- K for the year ended December 31, 2016 filed with the Securities and Exchange Commission and "Risk Factors" section included elsewhere i
8/9/17 - Impax Announces Settlement of Contract Litigation on Opana ER CII Extended Release Tablets
Release date- 08082017- HAYWARD, Calif.- Impax Laboratories, Inc., today announced a Settlement Agreement to resolve a contract dispute relating to an agreement entered into in June 2010 among Endo International plc, Penwest. Pharmaceuticals and Impax regarding the Abbreviated New Drug Application litigation related to the original formulation of O
8/9/17 - Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million
GAAP net loss was $20.4 million or a loss of $0.28 per share for the second quarter 2017, compared to a loss of $2.7 million or a loss of $0.04 per share in the prior year period, primarily due to restructuring and severance charges related to the Company's previously announced consolidation and improvement plan, charges related to certain potentia
8/9/17 - Implantable Drug Delivery Devices Market Analysis Report 2016-2023
The Implantable Drug Delivery Devices Market Research Report by DecisionDatabases.com provides industry analysis and evaluates the prospective market Size, Share, Growth, Trends and Forecast Till 2023.The global implantable drug delivery de...
8/9/17 - InfuSystem Holdings, Inc. Reports Second Quarter 2017 Financial Results
InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the United States, today reported financial results for the quarter ended June 30, 2017. Net revenues totaled $16.9 million, a decrease of 6.5%, versus the second quarter of 2016 of $18.1 million; Rental revenues decreased
8/9/17 - Ingestible drug-delivery materials may help patients comply with treatment regimens
By a News Reporter-Staff News Editor at Biotech Week CAMBRIDGE, MA Around half of all medications for chronic diseases are not taken as prescribed, costing the U.S. health care system more than $100 billion in avoidable hospital stays each year. To help ensure patients receive their full course of treatment, researchers at MIT and Brigham and W
8/9/17 - Inj.premix Analogue (300 I.u.) Of 30 Percentage Human Insulin Aspart And 70 Percentage Insulin Aspart Protamine, 3 Ml Catridge With Free Pen And Needles For Use Of The Drug.: (brand Name: Inj. Novomix 30 Penfill.) [TendersInfo (India)]
Quantity: 180.00 Numbers Bidding System: Single Bid System Inspection Agency: Others Payment Terms: As Per Annexure Attached At Special Conditions Of Contract For Medicines. As Per Drug Procurement Policy-2014, It Is Mentioned That Except Imported Drugs, If The Registered Firms Is/Are Marketing Drugs Manufactured By Other Manufacturing Units, Then.
8/9/17 - Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary GlobalData's new report, "Japan Drug Delivery Devices Market Outlook to 2023", provides key market data on the Japan Drug Delivery Devices market. The report provides value, in millions of US dollars and volume within market categories- Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices. Do
8/9/17 - Lupin receives USFDA approval for Nikita (Pitavastatin) tablets [India Infoline News Service]
Lupin announced that it has received a 505 NDA approval for its Nikita Tablets 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration. Lupin announced that it has received a 505 NDA approval for its Nikita Tablets 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration. Lupin Ltd ended at Rs 979, up by Rs 4.55 or 0.
8/9/17 - Neos Therapeutics Reports Second Quarter 2017 Financial Results
Release date- 08082017- DALLAS and FORT WORTH- Neos Therapeutics, Inc., a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified release drug delivery and orally disintegrating tablet technologies, today reported financial results for the second quarter...
8/9/17 - New Workflow Is First End-to-End Solution For Extrusion-Based Drug Implant Production
By a News Reporter-Staff News Editor at Biotech Week To meet growing demand for innovative drug delivery systems in the pharmaceutical industry, drug formulation scientists can now use the first commercially available, fully-integrated solution for polymer-based drug implant development and production using hot melt extrusion.
8/9/17 - Novel thermal ablation system for transdermal drug delivery
By a News Reporter-Staff News Editor at Biotech Week Many diseases are treated with protein-based drugs. In an attempt to produce a better drug delivery system, researchers from Kumamoto University in Japan focused on a transdermal protein delivery system. There are multiple techniques currently being studied for this type of drug delivery mechan
8/9/17 - Oral Controlled Release Drug Delivery Technology Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027
Further, with many big drug makers establishing a local manufacturing presence across various regions, the adoption of controlled release technology is expected to witness a growing spiral in the coming years especially in countries such as Brazil, Argentina, Costa Rica and Mexico. Download the full report: https://www.reportbuyer.com/product/50569
8/9/17 - Reports Outline Transdermal Delivery Findings from Health Effects Laboratory Division (Effect of stratum corneum heterogeneity, anisotropy, asymmetry...
By a News Reporter-Staff News Editor at Biotech Week Researchers detail new data in Drugs and Therapies- Transdermal Delivery. According to news reporting originating from Morgantown, West Virginia, by NewsRx correspondents, research stated, "The impact of the complex structure of the stratum corneum on transdermal penetration is not yet fully de
8/9/17 - Researchers at Indian Institute of Technology Bombay Describe Findings in Transdermal Delivery (Stratum corneum modulation by chemical enhancers and...
Researchers at Indian Institute of Technology Bombay Describe Findings in Transdermal Delivery. The news correspondents obtained a quote from the research from the Indian Institute of Technology Bombay, "The lipid lamellar structure comprises of ceramides, cholesterol, fatty acids and proteins. Our news journalists report that additional informatio
8/9/17 - Researchers at University of Southern Denmark Report New Data on Drug Delivery Systems (Simultaneous lipolysis/permeation in vitro model, for the...
According to news reporting originating in Odense, Denmark, by NewsRx journalists, research stated, "The simultaneous processes of lipid digestion and absorption together determine the oral bioavailability of drugs incorporated into lipid based drug delivery systems. The news reporters obtained a quote from the research from the University of South
8/9/17 - Russia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary GlobalData's new report, "Russia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Russia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume within market categories- Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
8/9/17 - SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference
SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that Jonathan M. N. Rigby, President and Chief Executive Officer, is scheduled to present at the 2017 Wedbush PacGrow Healthcare Conference in New Yo
8/9/17 - Studies from Medical University in the Area of Pharmacokinetics Described (Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following...
Studies from Medical University in the Area of Pharmacokinetics Described. The news reporters obtained a quote from the research from Medical University, "Pharmaceutical emulsion holds a significant place as a primary choice of oral drug delivery system for lipophilic drugs used in pediatric and geriatric patients. Our news correspondents report th
8/9/17 - Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results
Titan Pharmaceuticals, Inc., a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura? long-term, continuous drug delivery technology, today reported financial results for the second quarter 2017, and provided an update on its business. Second quarter license revenue from Probuphine was $
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415